AMRN Q1 2017 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+35.6% YoY

Gross Profit

$26M76.3% margin

Operating Income

-$19M-53.6% margin

Net Income

-$21M-60.5% margin

EPS (Diluted)

$-1.55

QoQ Revenue Growth

-10.5%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$175M

Total Liabilities

$204M

Stockholders' Equity

-$29M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$26M	+35.6%
Gross Profit	$26M	$19M	+41.8%
Operating Income	-$19M	-$23M	+19.7%
Net Income	-$21M	-$30M	+29.7%